New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients
Two-dimensional gel electrophoresis (2-DE) is often used to separate plasma or serum proteins in an attempt to identify novel disease biomarkers. A major problem with this approach is the presence of high abundant plasma/serum proteins which limit the detection of low abundance features. We used two...
| Κύριοι συγγραφείς: | , , , , , , , , , , |
|---|---|
| Μορφή: | Journal article |
| Έκδοση: |
OMICS International
2014
|
| _version_ | 1826284790758768640 |
|---|---|
| author | Gangadharan, B Antrobus, R Bapat, M Rossa, J Kumar, A Chittenden, D Kampa, B Barnes, E Klenerman, P Dwek, R Zitzmann, N |
| author_facet | Gangadharan, B Antrobus, R Bapat, M Rossa, J Kumar, A Chittenden, D Kampa, B Barnes, E Klenerman, P Dwek, R Zitzmann, N |
| author_sort | Gangadharan, B |
| collection | OXFORD |
| description | Two-dimensional gel electrophoresis (2-DE) is often used to separate plasma or serum proteins in an attempt to identify novel disease biomarkers. A major problem with this approach is the presence of high abundant plasma/serum proteins which limit the detection of low abundance features. We used two proteomic approaches to identify new fibrosis biomarkers in patients with different stages of liver fibrosis. Plasma samples from healthy individuals and patients with hepatitis C virus (HCV) induced cirrhosis were analysed using 2-DE over a narrow pH 3-5.6 range, arrange outside the pH of highly abundant albumin, transferrin and immunoglobulins. Several novel markers were identified by this approach and were validated across all fibrosis stages by Western blotting. This is the first time the pH 3-5.6 range has been used to separate plasma by 2-DE and was found to be beneficial for biomarker discovery. In addition, we used in-solution isoelectric focusing followed by SDS- PAGE to find biomarkers in HCV-induced liver cirrhosis. This approach was found to be beneficial for identifying basic, high molecular weight protein biomarkers. These approaches have successfully helped to identify novel biomarkers for hepatic fibrosis and these approaches are also useful for discovering novel biomarkers in other diseases. |
| first_indexed | 2024-03-07T01:19:09Z |
| format | Journal article |
| id | oxford-uuid:8fbd61dc-3ae9-4db8-9f59-1fcf40c8d663 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T01:19:09Z |
| publishDate | 2014 |
| publisher | OMICS International |
| record_format | dspace |
| spelling | oxford-uuid:8fbd61dc-3ae9-4db8-9f59-1fcf40c8d6632022-03-26T23:06:32ZNew proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patientsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8fbd61dc-3ae9-4db8-9f59-1fcf40c8d663Symplectic Elements at OxfordOMICS International2014Gangadharan, BAntrobus, RBapat, MRossa, JKumar, AChittenden, DKampa, BBarnes, EKlenerman, PDwek, RZitzmann, NTwo-dimensional gel electrophoresis (2-DE) is often used to separate plasma or serum proteins in an attempt to identify novel disease biomarkers. A major problem with this approach is the presence of high abundant plasma/serum proteins which limit the detection of low abundance features. We used two proteomic approaches to identify new fibrosis biomarkers in patients with different stages of liver fibrosis. Plasma samples from healthy individuals and patients with hepatitis C virus (HCV) induced cirrhosis were analysed using 2-DE over a narrow pH 3-5.6 range, arrange outside the pH of highly abundant albumin, transferrin and immunoglobulins. Several novel markers were identified by this approach and were validated across all fibrosis stages by Western blotting. This is the first time the pH 3-5.6 range has been used to separate plasma by 2-DE and was found to be beneficial for biomarker discovery. In addition, we used in-solution isoelectric focusing followed by SDS- PAGE to find biomarkers in HCV-induced liver cirrhosis. This approach was found to be beneficial for identifying basic, high molecular weight protein biomarkers. These approaches have successfully helped to identify novel biomarkers for hepatic fibrosis and these approaches are also useful for discovering novel biomarkers in other diseases. |
| spellingShingle | Gangadharan, B Antrobus, R Bapat, M Rossa, J Kumar, A Chittenden, D Kampa, B Barnes, E Klenerman, P Dwek, R Zitzmann, N New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients |
| title | New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients |
| title_full | New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients |
| title_fullStr | New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients |
| title_full_unstemmed | New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients |
| title_short | New proteomic approaches for biomarker discovery: The search for novel liver fibrosis markers in hepatitis C patients |
| title_sort | new proteomic approaches for biomarker discovery the search for novel liver fibrosis markers in hepatitis c patients |
| work_keys_str_mv | AT gangadharanb newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients AT antrobusr newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients AT bapatm newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients AT rossaj newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients AT kumara newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients AT chittendend newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients AT kampab newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients AT barnese newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients AT klenermanp newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients AT dwekr newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients AT zitzmannn newproteomicapproachesforbiomarkerdiscoverythesearchfornovelliverfibrosismarkersinhepatitiscpatients |